The Kuopio Atherosclerosis Prevention Study (KAPS): Effect of pravastatin treatment on lipids, oxidation resistance of lipoprotems, and atherosclerotic progression-Reference-Cited by-同舟云学术

The Kuopio Atherosclerosis Prevention Study (KAPS): Effect of pravastatin treatment on lipids, oxidation resistance of lipoprotems, and atherosclerotic progression

Published:1995-09 Issue:9 Volume:76 Page:34C-39C
ISSN:0002-9149
Container-title:The American Journal of Cardiology
language:en
Short-container-title:The American Journal of Cardiology

Author:

Salonen Riitta,Nyyssönen Kristiina,Porkkala-Sarataho Elina,Salonen Jukka T.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference13 articles.

1. Coronary angiographic changes with lovastatin therapy: the Monitored Atherosclerosis Regression Study (MARS);Blankenhorn;Am Intern Med,1993

2. Effect of simvastatin on coronary atheroma: the Multicenter Anti-Atheroma Study (MAAS);MAAS Investigators;Lancet,1994

3. Effect of lovastatin on early carotid atherosclerosis and cardiovascular events;Furberg;Circulation,1994

4. Pravastatin, lipids atherosclerosis in the carotid arteries (PLAC-II): a clinical trial with atherosclerosis outcome;Crouse;Am J Cardiol,1995

5. Ultrasound B-mode imaging in observational studies of atherosclerotic progression;Salonen;Circulation,1993

Cited by 94 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Carotid Stenosis and Stroke: Historical Perspectives Leading to Current Challenges;Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques;2024-03-11

2. Pharmacological interventions for asymptomatic carotid stenosis;Cochrane Database of Systematic Reviews;2023-08-04

3. Effect of Statin Therapy on the Plasma Concentrations of Retinol, Alpha-Tocopherol and Coenzyme Q10 in Children with Familial Hypercholesterolemia;Cardiovascular Drugs and Therapy;2020-10-14

4. Traditional Risk Factors are Causally Related to Carotid Intima-Media Thickness Progression: Inferences from Observational Cohort Studies and Interventional Trials;Current Pharmaceutical Design;2020-02-25

5. Intensive LDL cholesterol-lowering treatment beyond current recommendations for the prevention of major vascular events: a systematic review and meta-analysis of randomised trials including 327 037 participants;The Lancet Diabetes & Endocrinology;2020-01